0001104659-22-087403.txt : 20220808 0001104659-22-087403.hdr.sgml : 20220808 20220808174411 ACCESSION NUMBER: 0001104659-22-087403 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220806 FILED AS OF DATE: 20220808 DATE AS OF CHANGE: 20220808 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schroeder Theodore R CENTRAL INDEX KEY: 0001378690 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 221145698 MAIL ADDRESS: STREET 1: 12481 HIGH BLUFF DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25-28 NORTH WALL QUAY CITY: DUBLIN STATE: L2 ZIP: D01 H104 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 414 COMMERCE DRIVE STREET 2: STE 120 CITY: FORT WASHINGTON STATE: PA ZIP: 19034 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 4 1 tm2222534-14_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-08-06 0 0001641640 Nabriva Therapeutics plc NBRV 0001378690 Schroeder Theodore R 414 COMMERCE DR. SUITE 120 FORT WASHINGTON PA 19034 1 1 0 0 Chief Executive Officer Ordinary Shares 2022-08-06 4 F 0 225 0.1847 D 312309 D These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units. /s/ J. Christopher Naftzger, by power of attorney 2022-08-08